DFI Retail Group to Announce 2025 Half-year Financial Results and Host Analyst Presentation Live Webcast
Date: Wednesday, 23 July 2025
Time: 09:30 - 10:30 am (Hong Kong Time)
Presented by: Mr. Scott Price, Group Chief Executive and Mr. Tom van der Lee, Group Chief Financial Officer
Kindly RSVP by completing the form on or before Tuesday, 18 July 2025.
To avoid delays, we encourage participants to log in ten minutes ahead of the scheduled start time. A replay of the presentation will be available via webcast on DFI Retail Group's website.
Should you have any queries please email us at DFIComms@DFIretailgroup.com.
Hashtag: #DFIRetailGroup #Mannings #Guardian #7-Eleven #Wellcome #MarketPlace #ColdStorage #Giant #IKEA #yuu
The issuer is solely responsible for the content of this announcement.
DFI Retail Group
DFI Retail Group (the 'Group') is a leading Asian retailer, driven by its purpose to "Sustainably Serve Asia for Generations with Everyday Moments". The Group is dedicated to delivering quality, value and exceptional service to Asian consumers through a compelling retail experience, supported by an extensive store network and highly efficient supply chains. The Group, including associates and joint ventures, operates a portfolio of well-known brands across five key divisions: health and beauty, convenience, food, home furnishings, and restaurants.
DFI Retail Group
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
4 hours ago
- Zawya
India, New Zealand wrap up second round of FTA talks, next round in September
India and New Zealand concluded the second round of free trade agreement talks in New Delhi on Friday, making progress in areas including goods, services, investment, and trade facilitation, India's commerce ministry said. The talks, held from July 14 to 25, follow the launch of negotiations in March during New Zealand Prime Minister Christopher Luxon's visit to India. The third round will be held in New Zealand in September, with virtual meetings planned before then. This comes a day after India signed a trade pact with Britain and as it continues negotiations with the European Union and the United States. Both sides aim to conclude a "balanced, comprehensive and forward-looking" deal, the ministry said in a statement. India's merchandise trade with New Zealand rose 48.6% year-on-year to $1.3 billion in the 2024/25 fiscal year that ended in March. The proposed deal is expected to boost trade, investment, and supply chain resilience. (Reporting by Manoj Kumar; Editing by Emelia Sithole-Matarise)
Zawya
7 hours ago
- Zawya
South Africa: Mr Price retailer credits Easter, timely winter season for quarterly sales bump
South African clothing retailer Mr Price reported a 6.3% rise in its first-quarter sales on Wednesday, 23 July 2025, with comparable store sales up 3%, supported by the shift of Easter holidays into April and a timely winter season. Mr Price, which also sells furniture and homeware, said group sales grew to R9bn ($513m) in the three months to June 28 compared to the same quarter last year. The group recorded strong sales growth in April and May of 11.3% and 11.9%, respectively, due to the shift of Easter holidays into April and a timely winter season, with cold temperatures starting in late April, sooner than last year. This boosted demand for warm clothing and shoes in the first two months of the quarter. However, sales in June decreased by 5.1%, tracking declines across the market, prompting higher mark-downs in a highly promotional sector and reducing first-quarter gross profit margin by 20 basis points, Mr Price said. "The group exited the winter season clean and is comfortable with its closing stock position," the budget retailer said. Its clothing sales grew by 6%, while the homeware division increased sales by 6.4%. The telecoms segment continued its double-digit sales growth, increasing by 12.7%. Mr Price said it has gained more than R300m in market share from competitors over the last 12 months, "highlighting the effectiveness of its differentiated fashion-value offering."
Zawya
7 hours ago
- Zawya
Shanghai Healthcare M&A Fund Takes Strategic Stake in MicroPort Scientific Corporation
HONG KONG SAR - Media OutReach Newswire - 25 July 2025 – MicroPort Scientific Corporation (Stock Code: "MicroPort") announced that Shanghai Healthcare M&A Fund ("SHMAF"), a fund managed by SIIC Capital, a subsidiary of SIIC Group, has entered into a share purchase agreement to acquire 135,335,204 shares in MicroPort held by Otsuka Medical Devices Co., Ltd. Through this transaction, SHMAF will become a strategic shareholder in MicroPort, underscoring its role as a state-backed, professionally operated platform that is creating value and empowering, stabilizing, developing, and reshaping leading biopharmaceutical companies in China. As a homegrown Chinese innovator that has grown into a global leader in high-end medical devices, MicroPort serves as an anchor company for the industry. Its stable development is critical to both China's and the global high-end medical device supply chain. This investment reflects SHMAF's capital-driven approach to providing crucial support to domestic anchor companies, ensuring their stability and support growth of their core assets. SHMAF will support MicroPort's growth momentum and high-quality sustainable development with its expansive resources. Introducing a strategic shareholder to drive growth momentum. The transaction brings in a significant strategic shareholder for MicroPort. Leveraging its state-backed resources and industrial expertise, SHMAF will support MicroPort's development needs, core business expansion, and potential strategic mergers and acquisitions to create synergies that bolster the company's ongoing innovation and scale-up its operations. Optimizing resource allocation to unlock synergistic value. MicroPort has successfully incubated and nurtured multiple listed companies and specialized, highly influential small companies, in the process establishing a unique MicroPort ecosystem. SHMAF will leverage its capital and operational integration expertise to support MicroPort in refining its development strategy, optimizing resource allocation, and unlocking synergistic value—while fully respecting market dynamics and corporate autonomy—to further strengthen its ecosystem and competitive advantages. Enhancing ecosystem to enhance anchor company value. MicroPort's product portfolio spans across ten major verticals, including cardiovascular intervention, rhythm management, orthopaedics, neurovascular intervention, and surgical robotics, making it a core player in the high-end medical device industrial chain. SHMAF's support will not only drive MicroPort's growth, it will also accelerate its consolidation of upstream and downstream companies in Shanghai, attract highly-skilled talent, and facilitate breakthroughs in critical technologies and core components—ultimately enhancing the global competitiveness of China's high-end medical device industry. This transaction marks another significant step in SHMAF's commitment to serving biopharmaceutical anchor companies. Upholding its value investment principles, SHMAF will collaborate with MicroPort's shareholders and management team to leverage the strategic support and industrial synergies its state-backed platform offers. Together, they will reinforce MicroPort's position as China's innovation engine in high-end medical devices and contribute to the advancement of the biopharmaceutical industry. Hashtag: #SIICCapital #MicroPort #SHMAF The issuer is solely responsible for the content of this announcement. About MicroPort Scientific Corporation Founded in 1998 and headquartered in Shanghai's Zhangjiang, MicroPort Scientific Corporation is a leading domestic innovative high-end medical device group. It began by breaking the import monopoly in the cardiovascular stent field, and after 26 years of innovative development, its business has expanded to areas including rhythm management, orthopaedics, cardiovascular intervention, aortic and peripheral vascular intervention, neurovascular intervention, heart valves, surgical robots, and surgical medical devices. By the end of 2024, MicroPort operated in over 20,000 hospitals across 100 countries and regions worldwide, providing more than 600 solutions for patients covering over 200 diseases. MicroPort has incubated 6 A-share and Hong Kong-listed companies, owns 9 specialized and sophisticated SMEs, 4 technology giant enterprises, and 16 national high-tech enterprises, making it an outstanding representative of Shanghai's technological innovation and industrial transformation. About SIIC Capital As the active fund management platform under SIIC Group, since its establishment, SIIC Capital has been based in Shanghai, connected with Hong Kong, and oriented towards the world, actively exploring investment opportunities in strategic emerging industries such as biomedicine and green environmental protection. Through a multi-currency, full-stage fund matrix layout, it deeply serves national strategies and the construction of biomedicine highlands. SIIC Capital
